Atossa Genetics Regains NASDAQ Compliance
May 08, 2018 12:01 pm UTC| Business
SEATTLE, May 08, 2018 -- Atossa Genetics Inc. (NASDAQ:ATOS) (“Atossa” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast...
Microchip Technology Declares Quarterly Cash Dividend Of 36.35 Cents Per Share
May 08, 2018 12:01 pm UTC| Business
CHANDLER, Ariz., May 08, 2018 -- Microchip Technology Incorporated (NASDAQ:MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced that its Board of Directors has...
UroGen Pharma to Report First Quarter 2018 Financial Results on Tuesday, May 15, 2018
May 08, 2018 12:01 pm UTC| Business
Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, May 08, 2018 -- UroGen Pharma Ltd. (Nasdaq:URGN) today announced that it will report first quarter 2018 financial results on Tuesday,...
Profitect Wins Retailers’ Choice Award for Third Consecutive Year at RILA Retail Conference 2018
May 08, 2018 12:01 pm UTC| Business
BURLINGTON, Mass., May 08, 2018 -- Profitect Inc., the leading prescriptive analytics provider for the retail and CPG industry, today announced its third consecutive win of the Retailers’ Choice Award at the 2018 Retail...
May 08, 2018 12:01 pm UTC| Business
EDEN PRAIRIE, Minn., May 08, 2018 -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today its results for the first quarter ended March 31, 2018, which included the following highlights: Revenue for first quarter ended...
NXT Energy Solutions Announces Release Date for Its 2018 First Quarter Results and Conference Call
May 08, 2018 12:01 pm UTC| Business
CALGARY, Alberta, May 08, 2018 -- NXT Energy Solutions Inc. (“NXT” or the "Company") (TSX:SFD) (OTC QB:NSFDF) announces it will release its first quarter financial and operating results for the quarter ended March 31,...
May 08, 2018 12:01 pm UTC| Business
NEW HAVEN, Conn., May 08, 2018 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India